🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has taken down violative material and banned associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with numerous of members, populated with photos of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

Within moments of joining one group, a vendor shared contact information, where most purchases take place. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Information and Costs

Within these communities, messages show dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has already encountered individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to possibly serious health risks”.